New York Life Investment Management LLC
Position in GH — Guardant Health, Inc.
CIK 1133639
New York, NY
Position in GH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,521,854
+$1,105,915 QoQ
Shares Held
16,809
+9.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#242
of 594 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $87,400,583 across 13 Diagnostics & Research names. GH ranks #12 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
53,568 | $26,856,852 | |
| 2 | DHR |
Danaher Corp /De/
|
87,726 | $16,710,048 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
11,759 | $6,190,407 | |
| 4 | A |
Agilent Technologies, Inc.
|
42,302 | $5,618,974 | |
| 5 | WAT |
Waters Corp /De/
|
14,627 | $5,485,710 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
24,842 | $4,799,971 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
3,446 | $4,402,299 | |
| 8 | DGX |
Quest Diagnostics Inc
|
16,533 | $3,504,169 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,521,854 | 16,809 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,415,939 | 15,329 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,125,174 | 11,016 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||